Tag: global pharmaceutical companies
March 13, 2018
“China Will Become the Biggest Oncology Market in the World Over the Next 20 Years,” Says Chi-Med CEO Christian Hogg
Chi-Med, a China-based biopharmaceutical company, is making a name for itself within the oncology field at a global scale. April 10, 2017
Five Prime Completes Enrollment of Phase 2 Trial
Five Prime Therapeutics finished enrollment for an ongoing Phase 2 trial of Cabiralizumab treating Pigmented Villonodular Synovitis. January 19, 2017
Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology
Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced an exclusive license agreement with Stanford... December 14, 2016
Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)
Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting... November 14, 2016
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test
Thermo Fisher Scientific today reports it has submitted a premarket approval application to the FDA concerning its Oncomine Universal Dx... October 24, 2016
Aduro Biotech to Host Conference Call
Aduro Biotech today announced that it will hold a conference call to provide a corporate update tomorrow, October 24, 2016,... June 9, 2016